Health Catalyst (HCAT) Liabilities and Shareholders Equity (2018 - 2026)

Health Catalyst has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $412.2 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 53.77% year-over-year to $412.2 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (down 34.93% YoY), and the FY2025 full-year result was $502.6 million, down 41.48% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $412.2 million, down from $502.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $891.5 million in Q1 2025, with the low at $412.2 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $713.1 million across 5 years, with a median of $722.9 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 44.41% — and 2026, when it tumbled 53.77%.
• Health Catalyst's Liabilities and Shareholders Equity stood at $752.3 million in 2022, then declined by 6.71% to $701.8 million in 2023, then advanced by 22.39% to $858.9 million in 2024, then plunged by 41.48% to $502.6 million in 2025, then retreated by 17.99% to $412.2 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $412.2 million (Q1 2026), $502.6 million (Q4 2025), and $587.1 million (Q3 2025), per Business Quant data.